Showing results (111-120 of 391) with videos related to

Sort By:
Pageof 40
Clinical and Experimental Rheumatology|February 5, 2016
Decreased expression of methylene tetrahydrofolate reductase (MTHFR) gene in patients with rheumatoid arthritisSara Remuzgo-Martínez, Fernanda Genre, Raquel López-Mejías, et al.
Rheumatology (Oxford, England)|October 25, 2022
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 studyAndrew Östör, Filip Van den Bosch, Kim Papp, et al.
Biomed Research International|April 24, 2014
Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitisFernanda Genre, Raquel López-Mejías, José A Miranda-Filloy, et al.
Clinical and Experimental Rheumatology|March 15, 2013
Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapyFernanda Genre, José A Miranda-Filloy, Raquel López-Mejias, et al.
Reumatologia Clinica|November 10, 2016
Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexateRosario García-Vicuña, María Auxiliadora Martín-Martínez, María Rosa Gonzalez-Crespo, et al.
Internal and Emergency Medicine|March 4, 2025
Clinical characterization of aortitis and periaortitis: study of 134 patients from a single university hospitalCarmen Secada-Gómez, Javier Loricera, Adrián Martín-Gutiérrez, et al.
Reumatologia Clinica|August 13, 2018
Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid ArthritisJesús Tornero Molina, Alejandro Balsa Criado, Francisco Blanco García, et al.
Clinical and Experimental Rheumatology|November 30, 2020
Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritisDiana Prieto Peña, Isabel Martínez-Rodríguez, Belén Atienza-Mateo, et al.
Rheumatology International|November 14, 2018
Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet's disease associated uveitis: a systematic reviewAna Urruticoechea-Arana, Tatiana Cobo-Ibáñez, Virginia Villaverde-García, et al.
Pageof 40